GeneDx Holdings Corp. (NASDAQ:WGSWW – Get Free Report) was the recipient of a significant decline in short interest during the month of July. As of July 15th, there was short interest totaling 18,319 shares, a decline of 64.1% from the June 30th total of 50,980 shares. Based on an average trading volume of 59,199 shares, the short-interest ratio is currently 0.3 days.
GeneDx Price Performance
WGSWW opened at $0.00 on Tuesday. GeneDx has a 1-year low of $0.00 and a 1-year high of $0.13.
GeneDx Company Profile
GeneDx is a molecular diagnostics company specializing in high-complexity genetic testing for rare and ultra-rare inherited disorders. The company leverages next-generation sequencing (NGS) technologies, including whole exome sequencing, targeted gene panels, and chromosomal microarray analysis, to deliver comprehensive diagnostic insights. Its services are designed to support clinicians in identifying genetic mutations that underlie pediatric and adult conditions, guiding patient management, treatment decisions, and genetic counseling.
Founded in 2000 by Dr.
See Also
- Five stocks we like better than GeneDx
- 5 AI Stocks Are Pulling Back—Which Growth Catalysts Still Look Strongest?
- Middleby Is Betting a Leaner Business Can Unlock More Value
- 3 Value ETFs to Consider as Growth Stocks Lag Behind
- Wintrust: A Quiet Regional Bank Posting Loud Results
Receive News & Ratings for GeneDx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneDx and related companies with MarketBeat.com's FREE daily email newsletter.
